SCHEMBL6653526

SCHEMBL6653526

NC1=CCC=CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13730288 0.97
SCHEMBL9761067 0.67
SCHEMBL7423144 0.67
SCHEMBL3813633 0.67
SCHEMBL7265390 0.67
SCHEMBL3815061 0.64
Lithium Ion SCHEMBL8975741 0.63
SCHEMBL11669627 0.63
SCHEMBL7266811 0.62
SCHEMBL7266255 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8059654-A None JP disclosed
JP-52083672-A None JP disclosed
EP-3094333-B1 NO-RELEASING NITROOXY-CHROMENE CONJUGATES EUCLISES PHARMACEUTICALS INC (US) 2020-10-14 EP disclosed
EP-3351543-A1 1-(QUINOLIN-4-YL)-3-(6-(TRIFLUOROMETHYL)-PYRIDIN-2-YL)UREA AND 1-(QUINOLIN-4-YL)-3-(6-(TRIFLUOROMETHYL)-PYRAZINE-2-YL)UREA DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3 (GSK-3) INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AbbVie Deutschland GmbH & Co. KG (DE) 2018-07-25 EP disclosed
EP-1196383-B1 PROCESS FOR PREPARING AMLODIPINE BENZENESULPHONATE RICHTER GEDEON VEGYESZET (HU) 2004-12-01 EP disclosed
US-6596874-B1 Salt formation by reaction using benzenesulfonic acid RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2003-07-22 US disclosed
EP-1196383-A1 PROCESS FOR PREPARING AMLODIPINE BENZENESULPHONATE RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2002-04-17 EP disclosed
WO-2001002360-A1 PROCESS FOR PREPARING AMLODIPINE BENZENESULPHONATE Richter Gedeon Vegyészeti Gyár Rt. (HU) 2001-01-11 WO disclosed
US-5652251-A 6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation BAYER AKTIENGESELLSCHAFT (DE) 1997-07-29 US disclosed
EP-0515940-B1 New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions BAYER AG (DE) 1996-07-17 EP disclosed
US-3919246-A Process for preparing 2-amino-1,4-dihydropyridine derivates BAYER AG 1975-11-11 US disclosed
US-3919246-A Process for preparing 2-amino-1,4-dihydropyridine derivates BAYER AG 1975-11-11 US disclosed
US-3917622-A 2-Amino-1,4-dihydropyridine derivatives BAYER AG 1975-11-04 US disclosed
US-3917622-A 2-Amino-1,4-dihydropyridine derivatives BAYER AG 1975-11-04 US disclosed
US-3911123-A Pharmaceutical compositions utilizing 2-amino-1,4-dihydropyridine derivatives and method of effecting coronary vessel dilation and treating hypertension in humans and animals utilizing said compounds BAYER AG 1975-10-07 US disclosed
US-3911123-A Pharmaceutical compositions utilizing 2-amino-1,4-dihydropyridine derivatives and method of effecting coronary vessel dilation and treating hypertension in humans and animals utilizing said compounds BAYER AG 1975-10-07 US disclosed
US-3867393-A 2-Amino-1,4-dihydropyridine derivatives MEYER HORST 1975-02-18 US disclosed
US-3867393-A 2-Amino-1,4-dihydropyridine derivatives MEYER HORST 1975-02-18 US disclosed
US-3862162-A CERTAIN-2-AMINO-1,4-DIHYDRO-4-PHENYL-6-LOWER ALKYL (OR PHENYL)-3-PYRIDINECARBOXYLATES BAYER AG 1975-01-21 US disclosed
US-3857849-A 2-AMINO-1,4-DIHYDROPYRIDINE DERIVATIVES BAYER AG 1974-12-31 US disclosed